Meeting
2022 ASCO Genitourinary Cancers Symposium
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
Authors
Niamh M. Keegan
Memorial Sloan Kettering Cancer Center, New York, NY
Niamh M. Keegan , Samantha E Vasselman , Ethan Barnett , Barbara Nweji , Emily Carbone , Alexander Blum , Michael J. Morris , Dana E. Rathkopf , Susan F. Slovin , Daniel Costin Danila , Karen A. Autio , Howard I. Scher , Philip W. Kantoff , Wassim Abida , Konrad H. Stopsack
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 64)
DOI
10.1200/JCO.2022.40.6_suppl.064
Abstract #
64
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Prostate screening for men with inherited risk of developing aggressive prostate cancer: The PATROL study.
First Author: Heather H. Cheng
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world comparison of prostate-specific antigen (PSA) response in patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) or enzalutamide (ENZ).
First Author: Benjamin H. Lowentritt
Poster
2023 ASCO Annual Meeting
Enhancement in line of therapy (LoT) derivation from real-world data (RWD) from electronic health records (EHR) via integration of medical claims data.
First Author: Smita Agrawal
First Author: Sandhya Cautha